These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26841146)

  • 1. Assessing the Prevalence of Latent Tuberculosis among Health Care Providers in Zagazig City, Egypt Using Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test.
    El-Sokkary RH; Abu-Taleb AM; El-Seifi OS; Zidan HE; Mortada EM; El-Hossary D; Farag SE
    Cent Eur J Public Health; 2015 Dec; 23(4):324-30. PubMed ID: 26841146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases.
    Bartalesi F; Vicidomini S; Goletti D; Fiorelli C; Fiori G; Melchiorre D; Tortoli E; Mantella A; Benucci M; Girardi E; Cerinic MM; Bartoloni A
    Eur Respir J; 2009 Mar; 33(3):586-93. PubMed ID: 19047313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
    Matsumoto T; Yamazaki T
    Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of healthcare workers for latent tuberculosis infection in the low tuberculosis burden country: QuantiFERON-TB gold in tube test or tuberculin skin test?
    Keshavarz Valian S; Mahmoudi S; Pourakbari B; Abdolsalehi MR; Eshaghi H; Mamishi S
    Arch Environ Occup Health; 2019; 74(3):109-114. PubMed ID: 30516445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of QuantiFERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection.
    Vinton P; Mihrshahi S; Johnson P; Jenkin GA; Jolley D; Biggs BA
    Infect Control Hosp Epidemiol; 2009 Mar; 30(3):215-21. PubMed ID: 19191484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
    Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for tuberculosis infection in spanish healthcare workers: Comparison of the QuantiFERON-TB gold in-tube test with the tuberculin skin test.
    Alvarez-León EE; Espinosa-Vega E; Santana-Rodríguez E; Molina-Cabrillana JM; Pérez-Arellano JL; Caminero JA; Serrano-Aguilar P
    Infect Control Hosp Epidemiol; 2009 Sep; 30(9):876-83. PubMed ID: 19614541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
    Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
    J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tuberculin skin test and quantiferon-TB gold in tube test for diagnosis of latent tuberculosis infection in health care workers: A cross sectional study.
    Bozkanat E; Kaya H; Sezer O; Caliskan T; Kilic E; Ciftci F; Gumus S; Kartaloglu Z
    J Pak Med Assoc; 2016 Mar; 66(3):270-4. PubMed ID: 26968275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of latent tuberculosis infection rate between contacts with active tuberculosis and non-contacts.
    Yoo JW; Jo KW; Park GY; Shim TS
    Respir Med; 2016 Feb; 111():77-83. PubMed ID: 26725461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QuantiFERON®-TB Gold In-Tube assay vs. tuberculin skin test in Indonesian children living with a tuberculosis case.
    Rutherford ME; Nataprawira M; Yulita I; Apriani L; Maharani W; van Crevel R; Hill PC; Alisjahbana B
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):496-502. PubMed ID: 22325792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of QuantiFERON-TB Gold with tuberculin skin test for detection of latent tuberculosis infection before kidney transplantation.
    Kim JS; Cho JH; Park GY; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
    Transplant Proc; 2013 Oct; 45(8):2899-902. PubMed ID: 24157000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
    de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH
    Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Latent Tuberculosis among Healthcare Workers in an Egyptian Hospital Using Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test.
    Anwar MM; Ahmed DM; Elareed HR; Abdel-Latif RA; Sheemy MS; Kamel NM; Mohamed MF
    Indian J Occup Environ Med; 2019; 23(3):106-111. PubMed ID: 31920258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
    Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
    Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of QuantiFERON-TB-Gold In Tube assay for active and latent tuberculosis infection in investigation of tuberculosis outbreak in a university.
    Li CY; Chen HC; Cheng HY; Chian CF; Chang FY; Chen HI; Ku CH; Lin JC
    J Microbiol Immunol Infect; 2015 Jun; 48(3):263-8. PubMed ID: 24184001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Mycobacterium tuberculosis infection among healthcare workers in New Zealand: prospective comparison between the tuberculin skin test and the QuantiFERON-TB Gold In-Tube assay.
    Freeman JT; Marshall RJ; Newton S; Austin P; Taylor S; Chew TC; Gavaghan S; Roberts SA
    N Z Med J; 2012 Feb; 125(1349):21-9. PubMed ID: 22327155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent tuberculosis infection among health-care workers using Quantiferon-TB Gold-Plus in a country with a low burden for tuberculosis: prevalence and risk factors.
    Almohaya A; Aldrees A; Akkielah L; Hashim AT; Almajid F; Binmoammar T; Barry MA
    Ann Saudi Med; 2020; 40(3):191-199. PubMed ID: 32493098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the performance of QuantiFERON-TB Gold and Mantoux test in detecting latent tuberculosis infection among Iranian health care workers.
    Talebi-Taher M; Javad-Moosavi SA; Entezari AH; Shekarabi M; Parhizkar B
    Int J Occup Med Environ Health; 2011 Dec; 24(4):359-66. PubMed ID: 22086450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.